Citadel Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
35,232
+10,900
+45% +$323K ﹤0.01% 8362
2026
Q2
$731K Buy
24,332
+14,605
+150% +$403K ﹤0.01% 8966
2026
Q1
$215K Sell
9,727
-8,873
-48% -$199K ﹤0.01% 11267
2025
Q4
$421K Buy
18,600
+6,893
+59% +$154K ﹤0.01% 9439
2025
Q3
$259K Buy
+11,707
New +$252K ﹤0.01% 10679
2024
Q1
– Sell
-12,124
Closed -$203K – 14596
2023
Q4
$203K Buy
+12,124
New +$196K ﹤0.01% 9931
2023
Q1
– Sell
-16,022
Closed -$251K – 14742
2022
Q4
$251K Buy
+16,022
New +$272K ﹤0.01% 9691

Other funds holding BSTZ

Citadel Advisors's BSTZ Position: Q3 2026 in Review

Citadel Advisors increased its BlackRock Science and Technology Term Trust (BSTZ) stake by 45% in Q3 2026, buying an estimated $323K and bringing the position to 35,232 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #8362.

Citadel Advisors first reported a position in BSTZ in Q4 2022 and has held it in 7 quarters since. 144 funds tracked by Wall St. Rank hold BSTZ as of Q3 2026.

  • Citadel Advisors held 35,232 shares of BlackRock Science and Technology Term Trust worth $1.04M as of Q3 2026.
  • Citadel Advisors bought 10,900 BlackRock Science and Technology Term Trust shares in Q3 2026, an estimated $323K.
  • BlackRock Science and Technology Term Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #8362 holding.
  • Citadel Advisors first reported a position in BlackRock Science and Technology Term Trust in Q4 2022 and has held it in 7 quarters since.
  • 144 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.